Ng Li Yen, Gallagher Sarah, Walsh Kevin P
Department of Paediatric Cardiology, Children's Health Ireland at Crumlin, Cooley Road, Crumlin, Dublin D12 N512, Ireland.
Eur Heart J Case Rep. 2021 Jan 12;5(2):ytaa545. doi: 10.1093/ehjcr/ytaa545. eCollection 2021 Feb.
The SelectSecure lumenless 3830 pacing lead is often considered to be the pacing lead of choice for transvenous pacing in children because of its small diameter, lead strength, and reliable long-term sensing and pacing characteristics. One of the potential long-term pitfalls of a sturdy pacing lead is relative retraction with growth in children resulting in late lead dislodgement.
We report two cases of late SelectSecure 3830 lead dislodgement at 11.8 years (Case 1) and 8.8 years (Case 2), respectively, post the initial implantation. Case 1 was diagnosed with congenital complete heart block (CHB) at 9 months old when he presented with unconfirmed diphtheria infection. Case 2 was diagnosed with CHB at 14 weeks of age with positive maternal anti-Ro antibodies. Both patients underwent implantation of a transvenous permanent pacemaker implantation with Medtronic SelectSecure 3830 lead due to symptomatic bradycardia. Apart from a pulse generator change at 8.5 years (Case 1) and 7 years (Case 2), respectively, post-implant due to normal battery depletion, both patients are well in the interim.
As part of the pacemaker follow-up for rapidly growing children, we recommend more frequent surveillance of lead 'tautness' by chest radiography especially in children with CHB with no underlying heart rhythm.
SelectSecure无腔3830起搏导线因其直径小、导线强度高以及可靠的长期感知和起搏特性,常被认为是儿童经静脉起搏的首选起搏导线。坚固的起搏导线潜在的长期问题之一是随着儿童生长相对回缩,导致后期导线脱位。
我们报告了两例分别在初次植入后11.8年(病例1)和8.8年(病例2)出现的SelectSecure 3830导线晚期脱位病例。病例1在9个月大时因疑似白喉感染被诊断为先天性完全性心脏传导阻滞(CHB)。病例2在14周龄时因母亲抗Ro抗体阳性被诊断为CHB。由于出现症状性心动过缓,两名患者均接受了美敦力SelectSecure 3830导线经静脉永久起搏器植入术。除了分别在植入后8.5年(病例1)和7年(病例2)因电池正常耗尽更换脉冲发生器外,两名患者在此期间情况良好。
作为对快速生长儿童起搏器随访的一部分,我们建议通过胸部X线检查更频繁地监测导线“张力”,尤其是对于无潜在心律的CHB儿童。